These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33599744)

  • 1. Effective approaches to discover new microbial metabolites in a large strain library.
    Zdouc MM; Iorio M; Vind K; Simone M; Serina S; Brunati C; Monciardini P; Tocchetti A; Zarazúa GS; Crüsemann M; Maffioli SI; Sosio M; Donadio S
    J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 33599744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging a large microbial strain collection for natural product discovery.
    Steele AD; Teijaro CN; Yang D; Shen B
    J Biol Chem; 2019 Nov; 294(45):16567-16576. PubMed ID: 31570525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-guided investigation of secondary metabolites produced by a potential new strain Streptomyces BA2 isolated from an endemic plant rhizosphere in Turkey.
    Kum E; İnce E
    Arch Microbiol; 2021 Jul; 203(5):2431-2438. PubMed ID: 33666690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omics and multi-omics approaches to study the biosynthesis of secondary metabolites in microorganisms.
    Palazzotto E; Weber T
    Curr Opin Microbiol; 2018 Oct; 45():109-116. PubMed ID: 29656009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reinvigorated era of bacterial secondary metabolite discovery.
    Sidebottom AM; Carlson EE
    Curr Opin Chem Biol; 2015 Feb; 24():104-11. PubMed ID: 25461728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methodology of Screening New Antibiotics: Present Status and Prospects].
    Trenin AS
    Antibiot Khimioter; 2015; 60(7-8):34-46. PubMed ID: 26863741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of microbial natural products by activation of silent biosynthetic gene clusters.
    Rutledge PJ; Challis GL
    Nat Rev Microbiol; 2015 Aug; 13(8):509-23. PubMed ID: 26119570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking the potential of natural products in drug discovery.
    Wright GD
    Microb Biotechnol; 2019 Jan; 12(1):55-57. PubMed ID: 30565871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery from natural products.
    Gullo VP; McAlpine J; Lam KS; Baker D; Petersen F
    J Ind Microbiol Biotechnol; 2006 Jul; 33(7):523-31. PubMed ID: 16544162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant environmental libraries provide access to microbial diversity for drug discovery from natural products.
    Courtois S; Cappellano CM; Ball M; Francou FX; Normand P; Helynck G; Martinez A; Kolvek SJ; Hopke J; Osburne MS; August PR; Nalin R; Guérineau M; Jeannin P; Simonet P; Pernodet JL
    Appl Environ Microbiol; 2003 Jan; 69(1):49-55. PubMed ID: 12513976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of specialized metabolites by Streptomyces coelicolor A3(2).
    van Keulen G; Dyson PJ
    Adv Appl Microbiol; 2014; 89():217-66. PubMed ID: 25131404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters.
    Ochi K; Hosaka T
    Appl Microbiol Biotechnol; 2013 Jan; 97(1):87-98. PubMed ID: 23143535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of new tools for chemical biology research on microbial metabolites.
    Osada H
    Biosci Biotechnol Biochem; 2010; 74(6):1135-40. PubMed ID: 20530900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovering new bioactive molecules from microbial sources.
    Monciardini P; Iorio M; Maffioli S; Sosio M; Donadio S
    Microb Biotechnol; 2014 May; 7(3):209-20. PubMed ID: 24661414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insights into the Biosynthetic Logic of Ribosomally Synthesized and Post-translationally Modified Peptide Natural Products.
    Ortega MA; van der Donk WA
    Cell Chem Biol; 2016 Jan; 23(1):31-44. PubMed ID: 26933734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Biology Approaches to New Bisindoles.
    Alkhalaf LM; Du YL; Ryan KS
    Methods Enzymol; 2016; 575():21-37. PubMed ID: 27417923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs.
    Dvorak Z; Klapholz M; Burris TP; Willing BP; Gioiello A; Pellicciari R; Galli F; March J; O'Keefe SJ; Sartor RB; Kim CH; Levy M; Mani S
    Mol Pharmacol; 2020 Oct; 98(4):343-349. PubMed ID: 32764096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactive Natural Products from Animal Associated-Microbes.
    Tian Y; Li YL; Zhao FC
    Mini Rev Med Chem; 2017; 17(17):1588-1601. PubMed ID: 27781963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
    Rebets Y; Brötz E; Tokovenko B; Luzhetskyy A
    J Ind Microbiol Biotechnol; 2014 Feb; 41(2):387-402. PubMed ID: 24127068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in developing and applying Streptomyces chassis - A review].
    Xiao L; Deng Z; Liu T
    Wei Sheng Wu Xue Bao; 2016 Mar; 56(3):441-53. PubMed ID: 27382787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.